Biomarkers could give early warning of bipolar disorder

Bipolar disorder is a treatable disease, but it is often either misdiagnosed or not detected until too late--with sometimes devastating consequences. A research team that includes Michèle Wessa, of the Central Institute of Mental Health in Germany has conducted a systematic review of functional magnetic resonance imaging (fMRI) and discovered that there are possible biomarkers that could detect bipolar disorder before symptoms become too serious. "These results support and refine previously proposed neurobiological models of the disorder and suggest that an imbalance between cortical-cognitive and limbic brain networks may serve as a neurobiological marker of bipolar disorder," Wessa is quoted as saying in an article in PsychCentral. Item

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.